Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-22
2006-08-22
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S562000
Reexamination Certificate
active
07094797
ABSTRACT:
An organ fibrosis inhibitor, in particular, a liver fibrosis inhibitor is provided, which contains histidine, preferable together with cysteine and/or cystine as active ingredients. Owing to the combined use, a remarkable effect of inhibiting organ fibrosis, in particular, liver fibrosis can be shown. These substances are usable as the desired active ingredients in the form of a drug or in the form of a food and drink. There is also provided an organ fibrosis inhibitor comprising the active ingredients as described above either separately or as a combination of one of them with a mixture of the other two ingredients. Thus, it is possible to present organ fibrosis inhibitors such as a liver fibrosis inhibitor which are applicable in the form used in health foods for improving and maintaining liver function and foods and drinks for sick people, as well as drugs for various organ diseases caused by fibrosis such as liver diseases.
REFERENCES:
patent: 2829056 (1958-04-01), Kemmerer
patent: 4279917 (1981-07-01), Takami et al.
patent: 4499076 (1985-02-01), Ohashi et al.
patent: 5032608 (1991-07-01), Dudrick
patent: 5352691 (1994-10-01), Thomas
patent: 5571783 (1996-11-01), Montagne et al.
patent: 5658937 (1997-08-01), Thomas
patent: 5670201 (1997-09-01), Takahashi et al.
patent: 5719133 (1998-02-01), Schmidl et al.
patent: 5741807 (1998-04-01), Thomas
patent: 5922766 (1999-07-01), Acosta et al.
patent: 5955450 (1999-09-01), Breborowicz et al.
patent: 6329414 (2001-12-01), Thomas et al.
patent: 2003/0087870 (2003-05-01), Gilbertson
The Merck Index, 11th edition, published 1989, pp. 436, “cysteine” and “cystine”, 685 “Gelatin”and 746 “Histidine”.
Stedman's Medical Dictionary, 25th Ed. published 1990, pp 1097-1098, “organ”.
The Merck Manual of Diagnosis and Therapy, 14th edition, published 1982, pp 386-389 and 634-639.
Wang, et al.,Biosci. Biotechnol. Biochem., vol. 63, No. 2, pp. 319-322 (1999).
Horie Takashi
Ishizaki Sonoko
Nakajoh Megumi
Sonaka Ichiro
Ajinomoto Co. Inc.
Henley III Raymond J.
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
LandOfFree
Organ fibrosis inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Organ fibrosis inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organ fibrosis inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3617837